These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6616454

  • 1. Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-beta-D-arabinofuranosylcytosine in nonhuman primates.
    Lopez JA, Beardsley GP, Krikorian JG, Mortara RW, Agarwal RP.
    Cancer Res; 1983 Nov; 43(11):5190-3. PubMed ID: 6616454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia.
    Sutoh H, Yamauchi T, Gotoh N, Sugiyama M, Ueda T.
    Anticancer Res; 2003 Nov; 23(6D):5037-42. PubMed ID: 14981964
    [Abstract] [Full Text] [Related]

  • 8. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 9. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
    Colly LP, Willemze R, Honders W, vd Hoorn F, Edelbroek PM.
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):49-54. PubMed ID: 3859932
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Anai H, Sugimachi K.
    Anticancer Res; 1989 Jun; 9(1):41-4. PubMed ID: 2705754
    [Abstract] [Full Text] [Related]

  • 13. Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
    Berg SL, Brueckner C, Nuchtern JG, Dauser R, McGuffey L, Blaney SM.
    Cancer Chemother Pharmacol; 2007 May; 59(6):743-7. PubMed ID: 16953392
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI, Powell W.
    Cancer Invest; 1987 May; 5(4):293-9. PubMed ID: 3664332
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine.
    Ho DH, Neil GL.
    Cancer Res; 1977 Jun; 37(6):1640-3. PubMed ID: 870178
    [Abstract] [Full Text] [Related]

  • 16. Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam.
    Kim S, Khatibi S, Howell SB, McCully C, Balis FM, Poplack DG.
    Cancer Res; 1993 Apr 01; 53(7):1596-8. PubMed ID: 8453629
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice.
    Koller-Lucae SK, Suter MJ, Rentsch KM, Schott H, Schwendener RA.
    Drug Metab Dispos; 1999 Mar 01; 27(3):342-50. PubMed ID: 10064564
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H.
    Cancer Res; 1981 Jun 01; 41(6):2501-6. PubMed ID: 7237444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.